Gensia Inc. regulatory update

The European Committee for Proprietary Medicinal Product (CPMP) recommended marketing approval of GNSA's GenESA system for use in the diagnosis of coronary artery disease. Each of the 12 member European Community nations must issue a product license before marketing may start. GenESA was approved in Sweden on Dec. 9 to diagnose coronary artery disease in conjuction with electrocardiography, echocardiography and radionuclide imaging. ...